TARS · Tarsus Pharmaceuticals, Inc. · Executive Compensation

$70.76 +0.73 (+1.04%) At close · Oct 27 Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$3.15B

43.88M

Volume · Oct 27 747.97K Avg daily vol (3M) 843.45K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$726,333	—	$2,648,284	$2,651,487	$555,700	$36,175	$6,617,979
Jeffrey S. Farrow	Chief Financial Officer and Chief Strategy Officer	$541,667	—	$893,961	$895,011	$264,900	$82,078	$2,677,617
Seshadri Neervannan	Chief Operating Officer	$547,000	—	$893,961	$895,011	$267,300	$24,900	$2,628,172
Bryan Wahl	M.D., J.D. General Counsel	$500,833	—	$893,961	$895,011	$245,500	$24,900	$2,560,205

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$673,400	—	$3,370,153	$3,267,692	$532,800	$52,147	$7,896,192
Jeffrey S. Farrow	Chief Financial Officer and Chief Strategy Officer	$520,833	—	$1,168,959	$1,133,398	$307,200	$102,536	$3,232,926
Seshadri Neervannan	Chief Operating Officer	$527,333	—	$1,168,959	$1,133,398	$311,300	$53,699	$3,194,689
Aziz Mottiwala	Chief Commercial Officer	$492,633	—	$1,168,959	$1,133,398	$292,500	$51,372	$3,138,862
Elizabeth Yeu-Lin	Chief Medical Officer	$78,182	$25,000	$1,399,928	$1,548,238	—	$53,509	$3,104,857

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeffrey S. Farrow	Chief Financial Officer and Chief Strategy Officer	$343,751	$100,000	$1,678,310	$1,590,572	$241,200	$37,997	$3,991,830
Bobak Azamian	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$619,500	—	$1,029,364	$1,017,968	$450,300	$13,200	$3,130,332
Leonard Greenstein	Chief Financial Officer	$202,100	—	$411,746	$893,298	$71,552	$399,883	$1,978,579
Seshadri Neervannan	Chief Operating Officer	$500,000	—	$494,095	$488,623	$246,000	$13,200	$1,741,918

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$590,000	—	$876,822	$2,077,378	$324,500	$47,580	$3,916,280
Jose Trevejo	M.D., Ph.D Chief Medical Officer	$403,333	$150,000	$606,054	$1,642,347	$176,000	$40,057	$3,017,791
Bryan Wahl	M.D., J.D. General Counsel and Secretary	$420,000	—	$1,034,621	$880,641	$168,000	$31,087	$2,534,349

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	M.D., Ph.D. President, Chief Executive Officer and Board Chairman	$550,000	—	—	$6,029,589	$269,500	$21,634	$6,870,723
Dianne Whitfield	MSW Chief Human Resources Officer	$358,636	$194,599	—	$2,628,804	—	$25,665	$3,207,704
Bryan Wahl	M.D., J.D. General Counsel and Secretary	$345,000	$50,000	—	$2,081,421	$141,408	$9,113	$2,626,942

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	M.D., Ph.D. President, Chief Executive Officer and Director	$437,000	$211,484	—	$1,847,092	—	$14,820	$2,510,396
Seshadri Neervannan	Ph.D. . Chief Operating Officer	$199,621	$85,248	—	$1,926,633	—	$2,175	$2,213,677
Leo M. Greenstein	Chief Financial Officer	$256,023	$147,437	—	$418,703	—	$13,280	$835,443

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bobak Azamian	M.D. Ph.D. President, Chief Executive Officer and Director	$300,000	$116,137	—	—	—	—	$416,137

Executive changes

Person	Role	Change	Effective	Filed
David E.I. Pyott	Class III director	Appointed	2026-02-18	2026-02-18
Rosemary Crane	member of the Board of Directors	Resigned	2025-01-17	2025-01-17
Elizabeth Yeu, M.D.	member of the Company's board of directors	Resigned	2024-11-04	2024-11-05
Elizabeth Yeu, M.D.	Chief Medical Officer	Appointed	2024-11-04	2024-11-05
Jose Trevejo, M.D., Ph.D.	Chief Medical Officer	Resigned	2024-01-18	2024-01-18
Jeff Farrow	Chief Financial Officer and Chief Strategy Officer	Appointed	2023-04-24	2023-04-24
Bobak Azamian	Chairperson of the Board	Appointed	2022-12-02	2022-12-07
Wendy Yarno	Lead Independent Director	Appointed	2022-12-02	2022-12-07
Michael Ackermann	member of the Board and any committees of the Board	Resigned	2022-12-02	2022-12-07
Michael Ackermann	Chairperson of the Board	Resigned	2022-12-02	2022-12-07
Scott Morrison	Chairperson of the Audit Committee	Appointed	2022-10-06	2022-10-12
Scott Morrison	Class III director	Appointed	2022-10-06	2022-10-12

Leadership

Bobak Azamian CEO, Chairman
Jeffrey S. Farrow CFO
Leonard Greenstein CFO
Seshadri Neervannan COO
Bryan Wahl General Counsel
Andrew Goldberg Board Member
Bhaskar Chaudhuri Board Member
David E.I. Pyott Board Member
Elizabeth Yeu-Lin, M.D. Board Member
Katherine Goodrich Board Member
Rosemary A. Crane Board Member
Scott Morrison Board Member
Wendy Yarno Board Member
William J. Link Board Member

Key facts CIK 1819790 CUSIP 87650L103 13F (30d) 33 filings 33 filers Visit website Investor relations